Cover Image
DOI: https://doi.org/10.7203/jo3t.2.2.2018.11154

Chronic Kidney Disease - CKD [abstract]


Abstract


Total Number of CKD patients treated with OZONE THERAPY (rectal or IV saline): 40 (Most of them are under the treatment of Nephrologists)

Two categories:
- Serum Creatine <3 (Stage 1-2-3) No. of pts. 23
- Serum Creatine > 3 till 14 (Stage 4-5) No. of pts.17

1) Improvement observed for Stage 1-2-3 that is 1st category: On the basis of Clinical evaluation & Pathological criteria, 100% pts. improvement, with stable patho & physiological criteria, for more than 18 months
2) Improvement observed - for Stage 4-5 that is 2nd category:
- On the basis of Clinical evaluation & Pathological criteria, 80% pts. Improved - Clinically & Pathologically. (Stable for > 3 months).
- No improvement was observed in 20% of pts.
60% patients have shown Clinical & Pathological improvement & maintained for 6-12months.
80% patients have shown Clinical & Pathological improvement & maintained for 3-6 months.

Clinical improvement as follows:
- Anorexia decreased
- Sense of well-being improved
- Energy level increased
- Edema decreased
- No changes in weight except +/- 1kg.

Pathological improvement:
- Hb improved
- Serum Creatinine & Serum BUN reduction
- Proteinuria decreased.

Ozone rectal insufflation are found to be more effective than IV ozone saline.

Conclusion: Patients who received rectal ozone continuously for more then 10 procedures are better improved and could maintain the improvement.

Keywords


ozone therapy; chronic kidney disease

Full Text:

PDF

Refbacks

  • There are currently no refbacks.


WFOTJournal of Ozone Therapy (JO3T)
The Official Peer Reviewed Journal of the World Federation of Ozone Therapy (WFOT)
ISSN 2444-9865